| Pack Size | Qty | Lead Time | Price | Quantity |
Lot Number
CAS #
*This document is like a lab demo—an example Certificate of Analysis (COA) that showcases what a COA looks like but may not match the latest batch in all its glory. Think of it as a chemistry experiment: close, but not quite the final reaction!
Share
Total BLR Stock
:
Bulk Quote| IUPAC name | sodium;dihydrogen phosphate |
| canonical smiles | OP(=O)(O)[O-].[Na+] |
| inchi | InChI=1S/Na.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+1;/p-1 |
| inchi key | AJPJDKMHJJGVTQ-UHFFFAOYSA-M |
| molecular formula | NaH2PO4 |
| synonyms | |
| Compound Description |
| Molecular Weight: | 119.977 g/mol |
| Hydrogen Bond Donor Count: | 2 |
| Hydrogen Bond Acceptor Count: | 4 |
| Rotatable Bond Count: | 0 |
| Exact Mass: | 119.95883982 g/mol |
| Monoisotopic Mass: | 119.95883982 g/mol |
| Topological Polar Surface Area: | 80.6 Ų |
| Heavy Atom Count: | 6 |
| Formal Charge: | 0 |
| Complexity: | 61.9 |
| Isotope Atom Count: | 0 |
| Defined Atom Stereocenter Count: | 0 |
| Undefined Atom Stereocenter Count: | 0 |
| Defined Bond Stereocenter Count: | 0 |
| Undefined Bond Stereocenter Count: | 0 |
| Covalently-Bonded Unit Count: | 2 |
| Compound Is Canonicalized: | Yes |
| Related Compounds |
| hazard signal | Warning |
| hazard classes and categories | |
| precautionary statement codes | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
| hazard statements | |
| hazards summary | Emergency treatment: Inorganic phosphates. Inorganic phosphates can cause diarrhea, hyperphosphatemia, and hypocalcemia after ingestion. An adult died after receiving four sodium phosphate enemas within 24 hours. he had electrolyte abnormalities and died from cardiac arrest. A mild eye irritant in rabbits and humans. |
| toxicity summary | IDENTIFICATION AND USE: Sodium dihydrogen phosphate is a white crystalline powder. It is used as a pH buffer, in baking powders; in boiler water treatment; and as a dry acidulant and sequestrant for foods. In addition, it is a buffering agent ; acidulant ; builder ; metal phosphatizing reagent; mineral supplement; softening/conditioning agent ; textile dyeing/printing auxiliary. In medicine, it is used as an enema solution. HUMAN EXPOSURE AND TOXICITY: Purposeful or accidental ingestion of more than the recommended dosage of tablets might be expected to lead to severe electrolyte disturbances, including hyperphosphatemia, hypocalcemia, hypernatremia, or hypokalemia, as well as dehydration and hypovolemia, with attendant signs and symptoms of these disturbances. Certain severe electrolyte disturbances may lead to cardiac arrhythmias, seizure, renal failure, and death. Prolongation of the QT interval has been observed in some patients who were dosed with Visicol tablets . QT prolongation with Visicol tablets has been associated with electrolyte imbalances, such as hypokalemia and hypocalcemia. The estimated fatal dose of sodium phosphates is 50 g. Orally administered sodium phosphate-associated colonic mucosal abnormalities are infrequent but can mimic non-steroidal anti-inflammatory drug-induced injury or inflammatory bowel disease, and in particular must be differentiated from Crohn's disease. ANIMAL STUDIES: Doses of 250 g/kg by mouth produced diarrhea in rats, guinea pigs and rabbits. Six days of sodium dihydrogen phosphate treatment in rats consistently produced calcification of basement membranes of proximal tubules in the mid-cortex, followed by calcification of casts and basement membranes in the outer medulla and papilla after 10 days. Injection of 10.0 mg/chicken egg in air cell & yolk caused celosomia, exencephaly, microcephaly, brachygnathia, hyperplasia of heart, ablepharia, torticollis, microphthalmia, anophthalmia, coloma, ectromelia, phocomelia, buphthalmia, and cleft palate anomalies. In vitro mammalian chromosome aberration test in Chinese hamster lung fibroblasts without metabolic activation was negative. Study of the genotoxic potential of with the SOS chromatest in E. coli PQ37, PQ35 with and without metabolic activation was negative. |
| symptoms |
